Clinical Trial Update: EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders

View source ↗

Summary

A clinical trial update indicating a study on EGR2 and NLRP3 pathways in obstructive sleep apnea–related cognitive and mood disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Obstructive Sleep Apnea

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Obstructive Sleep Apnea-Hypopnea Syndrome, Anxiety Disorders | Status: RECRUITING